No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
SD Biosensor Inc is an in vitro diagnostic company. It is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The company researches and develops products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, and enzyme immunological reaction diagnosis products.
www.sdbiosensor.comNo one on the platform currently holds 137310.KS.
No tracked institution reports a position in 137310.KS as of their last filing.
No one on the platform has traded 137310.KS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $824.1B | +9.7% | $-264.00 | $-264.00–$-264.00 | — | 1 |
| 2027 | $908.9B | +10.3% | $-148.00 | $-148.00–$-148.00 | — | 1 |
| 2028 | $1.01T | +10.9% | $0.00 | $0.00–$0.00 | — | 0 |
| 2029 | $1.12T | +11.3% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-11-13 | $-199.76 | $532.00 | +366.3% |
| 2024-08-13 | $-198.89 | $-153.00 | +23.1% |
| $20650.00 |
| +1.72% |
| $931.5B |
| — |
| 096530.KQSeegene, Inc. | $32400.00 | +0.47% | $1.48T | — |
| 145720.KSDentium Co. Ltd. | $37450.00 | +0.40% | $323.0B | — |
Source: Financial Modeling Prep · peers by sector/industry